Recent advances and persistent challenges in the design of freeze-drying process for monoclonal antibodies - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pharmaceutical Development and Technology Année : 2022

Recent advances and persistent challenges in the design of freeze-drying process for monoclonal antibodies

Résumé

Monoclonal antibodies constitute nowadays an important therapeutic class and the number of approved molecules for clinical uses continues to increase, achieving considerable part of the therapeutic market. Yet, the stability in solution of these biopharmaceuticals is often low. That is why freeze-drying has been and remains the method of choice to obtain monoclonal antibodies in the solid state and to improve their stability. The design of freeze-drying process and its optimization are still topical subjects of interest and the pharmaceutical industry is regularly challenged by the requirements of quality, safety and efficiency set by the regulatory authorities. These requirements imply a deep understanding of each step of the freeze-drying process, developing techniques to control the critical parameters and to monitor the quality of the intermediate and the final product. In addition to quality issues, the optimization of the freeze-drying process in order to reduce the cycle length is of great interest since freeze-drying is known to be an energy-expensive and time-consuming process. In this review, we will present the recent literature dealing with the freeze-drying of monoclonal antibodies and focus on the process parameters and strategies used to improve the stability of these molecules and to optimize the FD process.
Fichier principal
Vignette du fichier
MFP_ PharmaceuticalDevelopmentandTechnology_2022_Hsein.pdf (684.36 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04032313 , version 1 (02-11-2023)

Identifiants

Citer

Hassana Hsein, Julie Auffray, Thierry Noel, Pierre Tchoreloff. Recent advances and persistent challenges in the design of freeze-drying process for monoclonal antibodies. Pharmaceutical Development and Technology, 2022, 27 (9), pp.942-955. ⟨10.1080/10837450.2022.2131818⟩. ⟨hal-04032313⟩
25 Consultations
100 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More